During the past decade, Centre Hospitalier de l'Ardenne conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de l'Ardenne" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 4 trials, followed by "Seagen Inc." with 3 trials sponsored, "Labo'Life" with 2 trials sponsored, "UNICANCER" with 2 trials sponsored and "Aravive, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de l'Ardenne" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 3 trials as a collaborator, "Gynecologic Oncology Group" with 3 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 2 trials as a collaborator and "Genmab" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de l'Ardenne" are "Breast Cancer" (3 trials), "Cervical Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Solid Tumors" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Centre Hospitalier de l'Ardenne" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de l'Ardenne" are "Drug" (21 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Avelumab" (3 trials), "Paclitaxel" (3 trials), "2LHERP®" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de l'Ardenne" are 13 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier de l'Ardenne". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centre Hospitalier de l'Ardenne, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de l'Ardenne, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".